Haraoui BP - Search Results

1

Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.

Lee YC, Lu B, Boire G, Haraoui BP, Hitchon CA, Pope JE, Thorne JC, Keystone EC, Solomon DH, Bykerk VP. Lee YC, et al. Among authors: haraoui bp. Ann Rheum Dis. 2013 Jun;72(6):949-54. doi: 10.1136/annrheumdis-2012-201506. Epub 2012 Jul 11. Ann Rheum Dis. 2013. PMID: 22791744 Free PMC article.

2

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial.

Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG, et al. Carette S, et al. Arthritis Rheum. 1994 Jan;37(1):32-40. doi: 10.1002/art.1780370106. Arthritis Rheum. 1994. PMID: 8129762 Clinical Trial.

3

Biologic agents in the treatment of rheumatoid arthritis.

Haraoui B, Strand V, Keystone E. Haraoui B, et al. Curr Pharm Biotechnol. 2000 Nov;1(3):217-33. doi: 10.2174/1389201003378915. Curr Pharm Biotechnol. 2000. PMID: 11469381 Review.

4

Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in canada.

Russell A, Haraoui B, Keystone E, Klinkhoff A. Russell A, et al. Clin Ther. 2001 Nov;23(11):1824-38; discussion 1791. doi: 10.1016/s0149-2918(00)80079-x. Clin Ther. 2001. PMID: 11768835 Review.

5

Role of adalimumab in the treatment of early rheumatoid arthritis.

Keystone EC, Haraoui B, Bykerk VP. Keystone EC, et al. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S198-9. Clin Exp Rheumatol. 2003. PMID: 14969077 Clinical Trial.

6

Role of infliximab in the treatment of early rheumatoid arthritis.

Keystone EC, Haraoui B, Bykerk VP. Keystone EC, et al. Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S200-2. Clin Exp Rheumatol. 2003. PMID: 14969078 Review.

7

Adalimumab therapy in rheumatoid arthritis.

Keystone E, Haraoui B. Keystone E, et al. Rheum Dis Clin North Am. 2004 May;30(2):349-64, vii. doi: 10.1016/j.rdc.2004.02.004. Rheum Dis Clin North Am. 2004. PMID: 15172045 Review.

8

Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.

Haraoui B, Keystone EC, Thorne JC, Pope JE, Chen I, Asare CG, Leff JA. Haraoui B, et al. J Rheumatol. 2004 Dec;31(12):2356-9. J Rheumatol. 2004. PMID: 15570634 Clinical Trial.

9

Musculoskeletal manifestations and autoimmune diseases related to new biologic agents.

Haraoui B, Keystone E. Haraoui B, et al. Curr Opin Rheumatol. 2006 Jan;18(1):96-100. doi: 10.1097/01.bor.0000198007.73320.6e. Curr Opin Rheumatol. 2006. PMID: 16344625 Review.

10

Etanercept in the treatment of rheumatoid arthritis.

Haraoui B, Bykerk V. Haraoui B, et al. Ther Clin Risk Manag. 2007 Mar;3(1):99-105. doi: 10.2147/tcrm.2007.3.1.99. Ther Clin Risk Manag. 2007. PMID: 18360618 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page